1. Home
  2. ARMP
  3. ARMP News

Latest Armata Pharmaceuticals Inc. (ARMP) News on July 27, 2024

Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

PR Newswire

16 days ago

Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection

Business Wire

2 months ago

Net Asset Value(s)

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Atea Pharmaceuticals Inc Earnings Call

Share on Social Networks: